Strategy

Exscientia raises $26 million, partners with Roche

Read more

IMI: Building a science infrastructure for Europe

Read more

A strategy for using AI in pharma R&D

Read more

Producing viral vectors on an industrial scale

Read more

Developing gene therapies: a manufacturing view

Read more

Novartis sets out its vision for pharma R&D

Read more

Light on the horizon for Swedish biopharma

Read more

Galecto raises €79 million in Series C round

Read more

Genmab looks ahead to next phase of growth

Read more

Targeting the genetic background of cancers

Read more